Extracellular vesicles from Candida albicans modulate immune cells function and play a protective role in fungal

Huijin Duan1, Fanyue Meng1, Xing Liu1

  • 1Department of Ophthalmology, The Affiliated Hospital of Qingdao University, Qingdao, 266003, China.

PubMed

Insights

Candida albicans extracellular vesicles (EVs) activate immune cells, enhancing their ability to fight fungal keratitis. Pre-exposure to these EVs reduces disease severity and improves outcomes in mouse models.

Area of Science:

  • Ophthalmology
  • Mycology
  • Immunology

Background:

  • Fungal keratitis (FK) is a severe corneal infection caused by fungi like Candida albicans.
  • Extracellular vesicles (EVs) from fungi are increasingly recognized for their roles in infection and immunity.
  • The immunomodulatory effects of Candida albicans EVs in the context of fungal keratitis remain largely unexplored.

Purpose of the Study:

  • To investigate the impact of Candida albicans extracellular vesicles (EVs) on immune cell function and their therapeutic potential in fungal keratitis.

Main Methods:

  • In vitro studies using polymorphonuclear cells (PMNs) and RAW264.7 macrophages stimulated with C. albicans EVs.
  • Assessment of immune cell activation, cytokine production, nitric oxide (NO) release, and phagocytic/fungicidal activity.
  • In vivo experiments involving subconjunctival injection of C. albicans EVs in C57BL/6 mice followed by C. albicans infection to evaluate keratitis severity and fungal load.

Main Results:

  • C. albicans EVs activated PMNs, increasing proinflammatory cytokine and NO secretion, and enhancing phagocytosis and killing of C. albicans.
  • EVs induced a proinflammatory response in RAW264.7 cells, boosting cytokine production, CCL2 expression, and C. albicans clearance.
  • In vivo, C. albicans EV pre-treatment significantly reduced keratitis severity, lowered fungal burden, and improved prognosis in infected mice.

Conclusions:

  • Candida albicans EVs modulate immune cell function, enhancing innate immune responses against C. albicans.
  • These EVs demonstrate a protective role in experimental fungal keratitis, suggesting potential as a therapeutic agent.

Related Concept Videos

Overview of Secretory Vesicles01:33

Overview of Secretory Vesicles

Secretory vesicles, also known as dense core vesicles (DCVs), are membrane-bound vesicles that transport secretory proteins, such as hormones or neurotransmitters. Regulated secretory vesicles transport proteins from the trans-Golgi network to the exterior of the cell. Proteins present in regulated secretory vesicles are required to be rapidly exocytosed in large amounts upon a specific stimulus.
Various proteins regulate the aggregation of molecules inside the secretory vesicles. Chromogranins...
8.5K
Regulation of Hematopoietic Stem Cells01:01

Regulation of Hematopoietic Stem Cells

All blood and immune cells are produced from the multipotent hematopoietic stem cells (HSCs) by the process of hematopoiesis. However, they all have a limited life span. In addition, many are depleted in immune surveillance or combatting an injury or infection. This makes blood one of the most regenerative tissues. Hematopoiesis helps replenish these blood and immune cells, restoring the body's normal functioning. However, overproduction of blood and immune cells can make them cancerous or...
3.2K
Immune Response Against Viral Pathogens01:29

Immune Response Against Viral Pathogens

The immune system's response to viral infections is a complex and coordinated process involving natural killer (NK) cells, T cell-mediated responses, and antibody-mediated responses.
NK Cells
NK cells are a crucial part of our innate immune system, acting as the first line of defense against viral infections. These cells can recognize and kill infected cells without prior exposure to the virus, effectively slowing down the spread of infection. Additionally, NK cells produce proinflammatory...
781
Overview of Exosomes01:36

Overview of Exosomes

Exosomes are stable, lipid bilayer-enclosed vesicles capable of crossing biological barriers. They can carry a wide range of molecules required for intercellular communication. Once exosomes are released from the cell where they originated, they enter a recipient cell through various pathways such as fusion, receptor-mediated endocytosis, macropinocytosis, and phagocytosis.
Stahl et al. discovered exosomes in 1983, but the exosomes were initially considered waste products released from the...
2.7K